These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6427998

  • 1. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.
    Dye ES, North RJ.
    Transplantation; 1984 Jun; 37(6):600-5. PubMed ID: 6427998
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES.
    J Immunol; 1986 Feb 15; 136(4):1510-5. PubMed ID: 3080526
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency analysis of augmented CTL production associated with Corynebacterium parvum-induced tumour regression.
    Johnson TR, North RJ.
    Immunology; 1987 Mar 15; 60(3):361-6. PubMed ID: 3106195
    [Abstract] [Full Text] [Related]

  • 9. In vitro expression of secondary antitumor immunity by in vitro tumor-sensitized T cells: inhibition by tumor-induced suppressor T cells.
    Kaymakcalan Z, Spitalny GL, Bursuker I.
    Cancer Immunol Immunother; 1987 Mar 15; 25(2):69-74. PubMed ID: 2959361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM, Rosenstein M, Von Glatz J, Hsu SM, Rosenberg SA.
    Lab Invest; 1985 Mar 15; 52(3):304-13. PubMed ID: 3974201
    [Abstract] [Full Text] [Related]

  • 12. Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells.
    Mills CD, North RJ.
    Transplantation; 1985 Feb 15; 39(2):202-8. PubMed ID: 3155882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.
    Hines DL.
    Cancer Immunol Immunother; 1989 Feb 15; 28(4):241-7. PubMed ID: 2495177
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
    Scott MT.
    J Natl Cancer Inst; 1975 Jul 15; 55(1):65-72. PubMed ID: 808637
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
    Lichtenstein A, Murahata R, Sugasawara R, Zighelboim J.
    Cell Immunol; 1981 Mar 01; 58(2):257-68. PubMed ID: 6452218
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
    North RJ.
    J Exp Med; 1982 Apr 01; 155(4):1063-74. PubMed ID: 6460831
    [Abstract] [Full Text] [Related]

  • 20. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L, McGowan P, Ashe S, Johnston JV, Hellström I, Hellström KE.
    Cancer Res; 1994 Oct 15; 54(20):5420-3. PubMed ID: 7522958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.